Literature DB >> 7746329

Specificity in chaperonin-mediated protein folding.

G Tian1, I E Vainberg, W D Tap, S A Lewis, N J Cowan.   

Abstract

Chaperonins are ubiquitous multisubunit toroidal complexes that aid protein folding in an ATP-dependent manner. Current models of folding by the bacterial chaperonin GroEL depict its role as unfolding and releasing molecules that have misfolded, so that they can return to a potentially productive folding pathway in solution. Accordingly, a given target polypeptide might require several cycles of binding and ATP-driven release from different chaperonin complexes before reaching the native state. Surprisingly, cycling of a target protein does not guarantee its folding, and we report here that unfolded beta-actin or alpha-tubulin both form tight complexes when presented to either GroEL or its mitochondrial homologue, and both undergo cycles of release and rebinding upon incubation with ATP, but no native protein is produced. We conclude that different chaperonins produce distinctive spectra of folding intermediates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746329     DOI: 10.1038/375250a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

1.  Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT.

Authors:  Jaime Martín-Benito; Jasminka Boskovic; Paulino Gómez-Puertas; José L Carrascosa; C Torrey Simons; Sally A Lewis; Francesca Bartolini; Nicholas J Cowan; José M Valpuesta
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

2.  Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).

Authors:  T V Damodaran; A Abdel-Rahman; M B Abou-Donia
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

3.  Disease-associated mutations in TUBA1A result in a spectrum of defects in the tubulin folding and heterodimer assembly pathway.

Authors:  Guoling Tian; Xavier H Jaglin; David A Keays; Fiona Francis; Jamel Chelly; Nicholas J Cowan
Journal:  Hum Mol Genet       Date:  2010-07-05       Impact factor: 6.150

4.  Proteomic analysis of 3T3-L1 preadipocytes having a higher cell proliferation rate after treatment with low-molecular-weight silk fibroin peptides.

Authors:  G Huang; G Li; H Chen; Y He; Q Yao; K Chen
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

Review 5.  Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets.

Authors:  Christoph Spiess; Anne S Meyer; Stefanie Reissmann; Judith Frydman
Journal:  Trends Cell Biol       Date:  2004-11       Impact factor: 20.808

6.  Modeling of possible subunit arrangements in the eukaryotic chaperonin TRiC.

Authors:  Erik J Miller; Anne S Meyer; Judith Frydman
Journal:  Protein Sci       Date:  2006-05-02       Impact factor: 6.725

7.  Cytosolic chaperonin protects folding intermediates of Gbeta from aggregation by recognizing hydrophobic beta-strands.

Authors:  Susumu Kubota; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

8.  Identification of the TRiC/CCT substrate binding sites uncovers the function of subunit diversity in eukaryotic chaperonins.

Authors:  Christoph Spiess; Erik J Miller; Amie J McClellan; Judith Frydman
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

9.  Essential function of the built-in lid in the allosteric regulation of eukaryotic and archaeal chaperonins.

Authors:  Stefanie Reissmann; Charles Parnot; Christopher R Booth; Wah Chiu; Judith Frydman
Journal:  Nat Struct Mol Biol       Date:  2007-04-29       Impact factor: 15.369

10.  A pachygyria-causing alpha-tubulin mutation results in inefficient cycling with CCT and a deficient interaction with TBCB.

Authors:  Guoling Tian; Xiang-Peng Kong; Xavier H Jaglin; Jamel Chelly; David Keays; Nicholas J Cowan
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.